MarketCap
Facebook
X
Telegram
NICE Ltd. Financial Ratios 2025-2007 | NICE
Brief overview of NICE Ltd.'s valuation multiples
The review covers five available annual periods spanning 2021 to 2025.
The current valuation set is P/E 11.83x (median 49.25x), EV/EBITDA 8.12x (median 25.57x), P/S 2.46x (median 6.24x). The combined multiple level is about 64.4% below the company's historical norm, suggesting more cautious expectations.
The 1/P/E calculation produces a 8.5% earnings yield. It does not capture future growth or capital structure.
Capital efficiency is characterized by ROE 15.8%, ROA 12%, ROCE 15.3%. Returns on capital and assets point to efficient economics and a strong internal source of growth.
On PEG (0.78x), valuation is restrained relative to growth, but one ratio cannot replace cash-flow and risk analysis.
The cash conversion cycle increased 38.1 days to 46.6 days, weakening working-capital efficiency.
Valuation takeaway
NICE Ltd. combines solid capital returns with a discount to its own history. The main question is whether earnings and growth are sustainable.
Annual Financial Ratios NICE Ltd.
| 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 | 2007 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
P/E |
11.8 | 20.4 | 49.3 | 51.4 | 96.1 | 90.4 | 51.8 | 41.7 | 38.8 | 35.5 | 13.9 | 28.2 | 43.4 | 33.2 | 39.7 | 36.5 | 34.4 | - | - |
P/S |
2.5 | 3.3 | 7.0 | 6.2 | 10.0 | 10.8 | 6.1 | 4.6 | 4.2 | 4.1 | 3.9 | 2.9 | 2.5 | 2.6 | 2.9 | - | - | - | - |
EPS |
9.8 | 7.0 | 5.3 | 4.2 | 3.1 | 3.1 | 3.0 | 2.6 | 2.4 | 2.0 | 4.3 | 1.7 | 0.9 | 1.1 | 0.9 | 0.8 | 0.7 | 0.7 | - |
EV (Enterprise Value) |
6.86 B | 8.49 B | 16.1 B | 13.1 B | 19.2 B | 19 B | 10.8 B | 7.59 B | 6.32 B | 5.12 B | 3.71 B | 3.15 B | 2.73 B | 2.63 B | 2.49 B | 1.67 B | 1.26 B | -144 M | -117 M |
EBITDA per Share |
13.6 | 11.8 | 9.48 | 8.02 | 7.09 | 6.76 | 6.63 | 5.78 | 5.07 | 2.54 | 3 | 2.32 | 1.84 | 1.32 | 1.31 | 1.69 | 1.39 | - | - |
EV/EBITDA |
8.1 | 11.3 | 26.7 | 25.6 | 42.7 | 59.2 | 39.1 | 28.7 | 29.3 | 29.5 | 18.4 | 19.7 | 20.6 | 26.9 | 25.0 | 15.7 | 14.7 | -1.8 | - |
PEG |
0.78 | 1.62 | 4.66 | 5.28 | 3.55 | 3.93 | 1.82 | 1.35 | 1.08 | -0.65 | 0.09 | 0.32 | -2.54 | 1.51 | 2.38 | - | - | - | - |
P/B |
1.4 | 1.7 | 3.2 | 2.8 | 4.1 | 6.9 | 4.3 | 3.3 | 3.2 | 2.7 | 2.5 | 2.4 | 2.0 | 1.9 | 2.0 | 1.2 | 1.1 | - | - |
P/CF |
10.1 | 10.8 | 29.5 | 28.4 | 41.5 | 37.0 | 25.8 | 16.7 | 14.1 | 22.5 | 15.9 | 17.7 | 23.3 | 21.3 | 17.1 | 12.3 | 12.3 | - | - |
ROE % |
15.79 | 12.24 | 10.07 | 8.71 | 7.03 | 7.60 | 8.24 | 7.90 | 8.19 | 7.74 | 18.29 | 8.49 | 4.59 | 5.70 | 4.94 | 4.20 | 4.02 | 4.03 | - |
ROA % |
11.99 | 8.30 | 6.58 | 5.46 | 4.24 | 4.65 | 5.15 | 4.97 | 5.04 | 4.44 | 13.99 | 6.28 | 3.34 | 4.09 | 3.62 | 3.17 | 3.05 | - | - |
ROCE % |
15.31 | 14.34 | 10.92 | 9.06 | 7.67 | 7.59 | 8.94 | 7.65 | 6.46 | 6.21 | 11.45 | 9.29 | 6.31 | 3.72 | 4.87 | 4.06 | 3.44 | 3.85 | - |
Current Ratio |
- | - | - | - | - | 2.6 | 2.7 | 2.7 | 2.6 | 1.1 | 1.6 | 1.3 | 1.2 | 1.4 | 1.5 | - | - | - | - |
DSO |
85.6 | 82.0 | 84.7 | 43.4 | 28.8 | 69.0 | 70.5 | 65.5 | 67.3 | 103.7 | 80.5 | 73.7 | 83.5 | 76.6 | 58.4 | - | - | - | - |
DIO |
- | - | - | - | - | - | - | - | 1.8 | 5.1 | 7.5 | 13.0 | 13.4 | 14.4 | 15.9 | 17.2 | 11.1 | - | - |
DPO |
39.0 | 35.4 | 29.0 | 24.6 | 20.2 | 20.6 | 20.6 | 21.7 | 21.4 | 27.7 | 14.1 | 11.6 | 26.0 | 21.4 | 22.6 | 31.4 | 20.3 | - | - |
Operating Cycle |
85.6 | 82.0 | 84.7 | 43.4 | 28.8 | 69.0 | 70.5 | 65.5 | 69.1 | 108.8 | 87.9 | 86.7 | 97.0 | 91.0 | 74.3 | 17.2 | 11.1 | - | - |
Cash Conversion Cycle |
46.6 | 46.6 | 55.7 | 18.8 | 8.6 | 48.3 | 49.9 | 43.8 | 47.6 | 81.1 | 73.8 | 75.2 | 71.0 | 69.7 | 51.7 | -14.3 | -9.2 | - | - |
All numbers in USD currency
Quarterly Financial Ratios NICE Ltd.
| 2025-Q4 | 2024-Q4 | 2023-Q4 | 2022-Q4 | 2022-Q3 | 2022-Q2 | 2022-Q1 | 2021-Q4 | 2021-Q3 | 2021-Q2 | 2021-Q1 | 2020-Q4 | 2020-Q3 | 2020-Q2 | 2020-Q1 | 2019-Q4 | 2019-Q3 | 2019-Q2 | 2019-Q1 | 2018-Q4 | 2018-Q3 | 2018-Q2 | 2018-Q1 | 2017-Q4 | 2017-Q3 | 2017-Q2 | 2017-Q1 | 2016-Q4 | 2016-Q3 | 2016-Q2 | 2016-Q1 | 2015-Q4 | 2015-Q3 | 2015-Q2 | 2015-Q1 | 2014-Q4 | 2014-Q3 | 2014-Q2 | 2014-Q1 | 2013-Q4 | 2013-Q3 | 2013-Q2 | 2013-Q1 | 2012-Q4 | 2012-Q3 | 2012-Q2 | 2012-Q1 | 2011-Q4 | 2011-Q3 | 2011-Q2 | 2011-Q1 | 2010-Q4 | 2009-Q4 | 2008-Q4 | 2007-Q4 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
EPS |
9.82 | 6.97 | 5.32 | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | 0.78 | 0.7 | 0.65 | - |
EBITDA per Share |
13.6 | 11.8 | 9.48 | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | 1.69 | 1.39 | - | - |
ROE % |
42.30 | 30.53 | 22.32 | 12.25 | 12.25 | 12.25 | 12.25 | 12.25 | 12.25 | 12.25 | 12.25 | 12.25 | 12.25 | 12.25 | 12.25 | 12.25 | 12.25 | 12.25 | 12.25 | 12.25 | 12.25 | 12.25 | 12.25 | 12.25 | 12.25 | 12.25 | 12.25 | 12.25 | 12.25 | 12.25 | 12.25 | 12.25 | 12.25 | 12.25 | 12.25 | 12.25 | 12.25 | 12.25 | 12.25 | 12.25 | 12.25 | 12.25 | 12.25 | 12.25 | 12.25 | 12.25 | 12.25 | 12.25 | 12.25 | 12.25 | 12.25 | 4.20 | 4.02 | 4.03 | - |
ROA % |
30.04 | 21.10 | 6.58 | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | 3.17 | 3.05 | - | - |
ROCE % |
44.63 | 32.76 | 22.27 | 11.35 | 11.35 | 11.35 | 11.35 | 11.35 | 11.35 | 11.35 | 11.35 | 11.35 | 11.35 | 11.35 | 11.35 | 11.35 | 11.35 | 11.35 | 11.35 | 11.35 | 11.35 | 11.35 | 11.35 | 11.35 | 11.35 | 11.35 | 11.35 | 11.35 | 11.35 | 11.35 | 11.35 | 11.35 | 11.35 | 11.35 | 11.35 | 11.35 | 11.35 | 11.35 | 11.35 | 11.35 | 11.35 | 11.35 | 11.35 | 11.35 | 11.35 | 11.35 | 11.35 | 11.35 | 11.35 | 11.35 | 11.35 | 4.06 | 3.44 | 3.85 | - |
DSO |
21.4 | 20.5 | 11.2 | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
DIO |
- | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | 4.3 | 2.8 | - | - |
DPO |
9.8 | 8.9 | 3.9 | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | 7.9 | 5.1 | - | - |
All numbers in USD currency
Multiples are an important financial analysis tool for the company NICE Ltd., allowing investors and analysts to quickly assess the company’s value and investment attractiveness based on the ratio of market indicators to the company’s financial performance. Essentially, multiples express how the market values the company relative to its earnings, revenue, equity, or other key metrics.
Advantages of Using Financial Ratios- Simplified Data Analysis
Financial ratios transform large volumes of accounting data into compact and easily interpretable indicators, significantly simplifying the assessment of the company’s condition. - Comparability Between Companies
Multiples standardize financial metrics, enabling objective comparison of companies of different sizes, industries, and market capitalizations. - Identification of Trends and Issues
Regular analysis of ratios helps track the dynamics of financial health, identify strengths and weaknesses of the business, as well as potential risks. - Decision Support
Financial multiples serve as an important tool for investors, creditors, and company management in making investment, credit, and managerial decisions. - Accelerated Assessment of Investment Attractiveness
Ratios allow quick determination of key performance, liquidity, and financial stability indicators, facilitating prompt evaluation of companies’ attractiveness for investments.
Using multiples enables comparison between companies, even if they differ in size or industry, as they standardize financial data into ratios convenient for analysis. This is especially useful for evaluating companies where direct analysis of financial statements may be complex or require in-depth knowledge.
Britain
Canada
USA
Israel
China
Curacao
Germany
